Improving the Knowledge of X-linked Hypophosphatemia among Clinicians in the Arabian Gulf and African Countries

M. Zulf Mughal

doi:10.1055/s-0042-1757704

Journal of Diabetes and Endocrine Practice, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2022; 05(02): 050-051
DOI: 10.1055/s-0042-1757704

Commentary

Improving the Knowledge of X-linked Hypophosphatemia among Clinicians in the Arabian Gulf and African Countries

M. Zulf Mughal

¹Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom

²School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom

References
1 Tosi LL, Rajah EN, Stewart MH, Gillies AP, Hart TS, Lewiecki EM. The Rare Bone Disease TeleECHO Program: leveraging telehealth to improve rare bone disease care. Curr Osteoporos Rep 2020; 18 (04) 344-349
2 Beshyah WS, Alsaffar H, Beshyah SA. Doctors' perceptions of rare bone disorders and X-linked hypophosphatemia: a survey from Africa and the Middle East. J Diabetes Endocr Pract 2022; 5: 65-72
3 Deeb A, Juraibah FA, Dubayee MA, Habeb A. X-linked hypophosphatemic rickets: awareness, knowledge, and practice of pediatric endocrinologists in Arab countries. J Pediatr Genet 2020; 11 (02) 126-131
4 Beck-Nielsen SS, Mughal Z, Haffner D. et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis 2019; 14 (01) 58
5 Che H, Roux C, Etcheto A. et al. Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol 2016; 174 (03) 325-333
6 Hawley S, Shaw NJ, Delmestri A. et al. Prevalence and mortality of individuals with X-linked hypophosphatemia: a United Kingdom real-world data analysis. J Clin Endocrinol Metab 2020; 105 (03) e871-e878
7 Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 2009; 160 (03) 491-497
8 Ferizović N, Marshall J, Williams AE. et al. Exploring the burden of X-linked hypophosphataemia: an opportunistic qualitative study of patient statements generated during a technology appraisal. Adv Ther 2020; 37 (02) 770-784
9 Seefried L, Smyth M, Keen R, Harvengt P. Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review. Osteoporos Int 2021; 32 (01) 7-22
10 Rafaelsen S, Johansson S, Ræder H, Bjerknes R. Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications. Eur J Endocrinol 2016; 174 (02) 125-136
11 Haffner D, Emma F, Eastwood DM. et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 2019; 15 (07) 435-455
12 Al Juraibah F, Al Amiri E, Al Dubayee M. et al. Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries. Arch Osteoporos 2021; 16 (01) 52
13 Mäkitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E. Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 2003; 88 (08) 3591-3597
14 Fukumoto S. FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment. J Mol Endocrinol 2021; 66 (02) R57-R65
15 Focus on FOP. Raising awareness and recognition of fibrodysplasia ossificans progressiva. Accessed August 14, 2022 at: https://www.tinsoldiers.org/what-is-fop